Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FSYYN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,071
Award facts
- Contract value 100% obligated
- $2,070.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for Nexplanon 68 mg implants, valued at $2,070.69. The award, issued on September 29, 2025, with an ultimate completion date of October 21, 2025, represents a specific product delivery under DMS's existing Indefinite Delivery Contract with the DLA. No set-aside designation was used for this particular delivery order, allowing the vendor to compete on an unrestricted basis. The place of performance is located in Park Ridge, Illinois, where DMS maintains its operations as a registered SAM.gov entity since 2001.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. This overarching contract vehicle, established under the SPE2DB program, enables the DLA to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. Nexplanon implants, a contraceptive device, represent one component of DMS's extensive pharmaceutical portfolio that includes prescription medications, biologics, vaccines, and specialty drugs. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution services to military health facilities and federal healthcare systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FSYYN?
SPE2DB25FSYYN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FSYYN worth?
The government has obligated $2,071 on SPE2DB25FSYYN.
Is contract SPE2DB25FSYYN an order under another contract?
Yes. SPE2DB25FSYYN is a delivery order under SPE2DB25D9349, an indefinite delivery contract.
Was contract SPE2DB25FSYYN competed?
The extent of competition for SPE2DB25FSYYN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award